<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00743145</url>
  </required_header>
  <id_info>
    <org_study_id>5693</org_study_id>
    <nct_id>NCT00743145</nct_id>
  </id_info>
  <brief_title>Effects of Low-dose Naltrexone in Combination With a Range of Smoked Marijuana</brief_title>
  <official_title>Effects of Low-dose Naltrexone in Combination With a Range of Smoked Marijuana</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York State Psychiatric Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Research Foundation for Mental Hygiene, Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>New York State Psychiatric Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine how naltrexone shifts the marijuana-response curve,
      a single, low-dose of naltrexone (12 mg/70 kg) or placebo will be administered 45 minutes
      before smoking marijuana (0,2,4,6,puffs of 6.2% THC). Naltrexone (12 mg/70 kg) or placebo
      will be administered 45 minutes before smoking to assess how opioid receptor blockade affects
      marijuana's subjective and physiologic effects. It is predicted that increasing the number of
      puffs of active marijuana will increase positive subjective ratings of marijuana and
      naltrexone and further increase these ratings.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Laboratory animal studies have convincingly demonstrated that opioid antagonists decrease the
      behavioral effects of cannabinoids. By contrast, in humans, the opioid antagonist naltrexone
      (12, 25, 50 and 100 mg) increases the subjective effects of a single strength of smoked
      marijuana (3.27% THC). A logical follow up to this finding is to determine how naltrexone
      shifts the marijuana-response curve. In the present study a single low dose of naltrexone (12
      mg/70 kg, po) will be administered prior to a range of puffs of a marijuana cigarette (0, 2,
      4, 6, puffs of 6.2% THC.) Non-treatment-seeking marijuana smokers will be recruited for an
      eight-session study during which the subjective, cognitive, and physiologic effects of smoked
      marijuana will be evaluated. Naltrexone (12 mg/70 kg, po) or placebo will be administered 45
      minutes before smoking to assess how opioid receptor blockade effects marijuana's subjective
      and physiologic effects.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2008</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>subjective effects</measure>
    <time_frame>8 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>cardiovascular effects</measure>
    <time_frame>8 hours</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>cognitive effects</measure>
    <time_frame>8 hours</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">49</enrollment>
  <condition>Marijuana Smoking</condition>
  <arm_group>
    <arm_group_label>naltrexone, marijuana</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>naltrexone (0, 12, 25, 50, 100 mg) marijuana (active, placebo)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo, marijuana</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Naltrexone</intervention_name>
    <description>12 mg/70kg</description>
    <arm_group_label>naltrexone, marijuana</arm_group_label>
    <other_name>Revia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>marijuana</intervention_name>
    <description>0,2,4, or 6 puffs of 6.2% THC</description>
    <arm_group_label>naltrexone, marijuana</arm_group_label>
    <arm_group_label>placebo, marijuana</arm_group_label>
    <other_name>cannabis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Current marijuana use

          -  Able to perform study procedures

          -  Women practicing an effective form of birth control

        Exclusion Criteria:

          -  Current repeated illicit drug use (other than marijuana)

          -  Presence of significant medical illness (e.g., diabetes, cardiovascular
             disease,hypertension, hepatitis, clinically significant laboratory abnormalities, LFTs
             &gt; 3x upper limit of normal, blood pressure &gt; 140/90
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Margaret Haney, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York State Psychiatric Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New York State Psychiatric Institute</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 26, 2008</study_first_submitted>
  <study_first_submitted_qc>August 26, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 28, 2008</study_first_posted>
  <last_update_submitted>October 25, 2016</last_update_submitted>
  <last_update_submitted_qc>October 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>naltrexone</keyword>
  <keyword>smoked marijuana</keyword>
  <keyword>marijuana use</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Marijuana Abuse</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Naltrexone</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>August 14, 2017</submitted>
    <returned>September 14, 2017</returned>
    <submitted>March 1, 2018</submitted>
    <returned>March 30, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

